R Moriev, O Vasylchenko, M Platonov, O Grygorenko, K Volkova, S Zozulya
Index: Acta Naturae 5(2) , 90-9, (2013)
Full Text: HTML
The aim of this study was to identify small molecule compounds that inhibit the kinase activity of the IGF1 receptor and represent novel chemical scaffolds, which can be potentially exploited to develop drug candidates that are superior to the existing experimental anti-IGF1R therapeuticals. To this end, targeted compound libraries were produced by virtual screening using molecular modeling and docking strategies, as well as the ligand-based pharmacophore model. High-throughput screening of the resulting compound sets in a biochemical kinase inhibition assay allowed us to identify several novel chemotypes that represent attractive starting points for the development of advanced IGF1R inhibitory compounds.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
PQ 401
CAS:196868-63-0 |
C18H16ClN3O2 |
|
IGFBP-2 directly stimulates osteoblast differentiation.
2014-11-01 [J. Bone Miner Res. 29(11) , 2427-38, (2014)] |
|
Diarylureas are small-molecule inhibitors of insulin-like gr...
2006-04-01 [Mol. Cancer Ther. 5 , 1079-1086, (2006)] |
|
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fus...
2016-03-01 [J. Pathol. 238 , 543-9, (2016)] |
|
PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits g...
2016-01-01 [J. Chemother. 28 , 44-9, (2016)] |
|
Reduced expression of EI24 confers resistance to gefitinib t...
2015-11-01 [Lung Cancer 90 , 175-81, (2015)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
